chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Positive Covid rapid test; A spontaneous report was received from a consumer concerning a 62-years-old female patient who received Moderna's COVID-19 vaccine and tested positive for COVID-19 rapid test.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 23 Dec 2020, prior to onset of the events, the patient received their dose of mRNA-1273 (Lot/batch number: unknown), for prophylaxis of COVID-19 infection.  On 28 Dec 2020, the patient tested positive for COVID-19 rapid test. The patient does not have any symptoms. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event positive COVID-19 test was not reported.; Reporter's Comments: Based on the current available information, patient testing positive for COVID-19 is unlikely related to vaccine. Very limited information regarding this event has been provided at this time.
After I had my vaccine, a few days later I had a true float with Epsom salt to just relax (location where you float in pond with a lot of Epsom salt to help with everything and relaxing).  the next day I started have this pain in my neck and back. I've had pain like muscle spasms before in my back but this was pain on a scale of 7 or 8 out of 10. On the 8th of June, I knew I would be travelling and knew I had to do something, so I asked one of my coworkers. He said maybe he could do some trigger points to help with the pain. I had already been seeing a physical therapists for some back pain and left hip pain. I've been to physical therapy twice since it started, and have been using biofreeze. I also use a muscle relaxant occasionally and about 800 mg of Ibuprofen when i need to. With the pain I also noticed I have a sleep number bed and started putting it into the "free gravity" setting (which i didn't normally do) and the left side of my bottom lip became numb. I have felt it since then occasionally as well, not as strong but still noticeable. Its a very specific area around T1 that is hurting off and on. I can press the area and its a very strange sensation.
HA, dizziness, nausea - 1-2 hours after vaccine ER visit.
Little bit cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Little bit cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced COUGH (Little bit cough). At the time of the report, COUGH (Little bit cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-077934 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.- MOD-2021-077934:case for wife
Information has been received from a RN concerning a 6 year old male who on 09/16/98 was vaccinated with a first dose of varicella virus vaccine live (Lot # 627330/1052H).  On 12/01/03 the pt had "50 vesicles in different stages all over." A MD visit was required and the pt was treated with Aveeno, Benadryl, Calamine and Tylenol. No diagnostic tests were performed. Subsequently, the pt recovered. Additional information is not expected.
My arm is very red and warm about 4 inches around the injection site; arm is very warm about 4 inches around the injection site; Fever of 101.4; Dizzy; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 62-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Sep2021 15:45 (Lot number: FC3183) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 15Sep2021 16:00, outcome "not recovered", described as "My arm is very red and warm about 4 inches around the injection site"; VACCINATION SITE WARMTH (non-serious) with onset 15Sep2021 16:00, outcome "not recovered", described as "arm is very warm about 4 inches around the injection site"; PYREXIA (non-serious) with onset 15Sep2021 16:00, outcome "not recovered", described as "Fever of 101.4"; DIZZINESS (non-serious) with onset 15Sep2021 16:00, outcome "not recovered", described as "Dizzy". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site warmth, pyrexia, dizziness. Additional information: Patient did not have known allergies or other medical history. Patient did not have other vaccine in four weeks. Events did not result to visit physician office or emergency room. Patient did not have COVID-19 tested post vaccination.
Pt recvd 2 doses of Engerix-B & following 2nd dose exp nausea & vomiting & 4 day's following doses exp bilateral lower extremity edema;
This spontaneous report was received from a medical assistant and refers to a 20 year old male patient. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided. On 08-MAY-2018, the patient was vaccinated at the physician's office with a dose of VAQTA injection, 50/1.0 U/ml, dose 50 U, intramuscularly, lot # N032753, expiration date 23-MAR-2019 and at the unspecified pharmacy with a dose of HAVRIX 1440EL U (exact dose, route of administration, lot# and expiration date were not reported). No adverse effects were reported.
Feb 17, I got my 1st  Moderna Covid19 shot.  Two weeks later staring March 1 for at least 4 days left arm has swollen red itchy area & injection site started to look like a little bruise.  Everything went well day of injection.  Prior to March 1 there was nothing. I couldn?t even tell where injection site was located. Described  condition over telephone to my Primary Care office.  They and I concluded Covid Arm.
This spontaneous report was received from a pharmacist and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. On an unknown dates (starting in January 2015), unspecified number of patients were administered an unspecified number of improperly stored doses of GARDASIL (dose, route of administration, injection site, lot# and expiration date were not reported). Administered doses of GARDASIL underwent temperature excursions at unspecified room temperature, for unknown time frames (since January 2015). Information about the previous temperature excursions was not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Moderna COVID-19 Vaccine EUA.   Note: I am a retired physician.   Minor soreness at injection next day resolved over48 hours.  Then, 7 days after receiving vaccine, I developed a pruritic swelling a few inches below injection site.  Next day (day 8) noted 4-5" diameter area of slight swelling and erythema below injection site.  Pruritis  became mild ache. No warmth.  Note: when I received vaccine there was a little acute bleeding from injection site,  then over next few days I developed a 2" diameter dark ecchymosis at site, still present on day 10, possibly lighter.  On day 10 note minimal swelling and erythema extending dow n from injection site in a rough triangle ~ 5-6" high with apex just below injection site, seems to be resolving.
After my first dose the ringing in my ears started; few days of brain fog; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (After my first dose the ringing in my ears started) and FEELING ABNORMAL (few days of brain fog) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020821A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Septra). Concomitant products included RIZATRIPTAN BENZOATE (MAXALT) from 01-Jan-2010 to an unknown date for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced TINNITUS (After my first dose the ringing in my ears started) and FEELING ABNORMAL (few days of brain fog). At the time of the report, TINNITUS (After my first dose the ringing in my ears started) and FEELING ABNORMAL (few days of brain fog) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other treatment medication include muscle relaxer, this did not help.   This case was linked to MOD-2021-184155 (Patient Link).
pt recvd vax; t 102 or 105; pt sleepy, super tired; not eating; dry cough; not really conscious; lt deltiod edema tender, erythema into neck to mid forearm; pt emotional & crying easier; PT on antibiotic;
72 hours later he got shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (72 hours later he got shingles) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     The patient's past medical history included Spinal cord injury, Aortic valve disease (clogged aortic valve in his heart.), Back surgery (2 surgeries.), Cholecystectomy and Heart valve replacement (an artificial valve in his heart). Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE SULFATE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE SULFATE]), CALCIUM, ZINC, UBIDECARENONE (COQ10 [UBIDECARENONE]), METHYLSULFONYLMETHANE (MSM [METHYLSULFONYLMETHANE]), COLECALCIFEROL (VITAMIN D3), FISH OIL (OMEGA 3 6 9 [FISH OIL]), VITAMIN E NOS, VITAMIN C [ASCORBIC ACID], MULTIVITAMIN [VITAMINS NOS] and FISH OIL (OMEGA 3 FISH OIL [FISH OIL]) for an unknown indication.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HERPES ZOSTER (72 hours later he got shingles) (seriousness criterion medically significant). The patient was treated with LORAZEPAM ongoing since an unknown date for Pain, at an unspecified dose and frequency and GABAPENTIN for Shingles, at a dose of 100 mg. At the time of the report, HERPES ZOSTER (72 hours later he got shingles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded. Further information has been requested.
This spontaneous report was received from a nurse concerning to a patient of an unknown age and gender. Information regarding the patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications was not reported. On 20-MAR-2019, the patient was vaccinated with a dose of PROQUAD 0.5ml, intramuscularly, lot # R026721, expiration date 17-MAR-2020 for prophylaxis. The vaccine were reconstituted with sterile diluent (lot # and expiration date not provided). On the same date, the patient's parent insisted that PROQUAD was administered intramuscularly instead of subcutaneously (incorrect route of product administration). No adverse events were reported. On 21-MAR-2019, the patient would be seen in office for evaluation. At the reporting time, the outcome of incorrect route of product administration was unknown.
Pt claims nauseated and very uncomfortable all day Monday 7/16/18. She felt better by 7/17.
This spontaneous report was received from a physician referring to a 5-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 21-AUG-2017, the patient was vaccinated with improperly stored ROTATEQ orally, lot # M041184 with expiration date on 31-MAY-2018 for prophylaxis (dose was not provided). The vaccine was exposed to a temperature of 49 Fahrenheit degrees for 16 hours on 20-MAY-2017, 17-JUN-2017 and 21-JUN-2017. The vaccine was exposed to a temperature of 48 Fahrenheit degrees for 16 hours on 27-MAY-2017, 02-JUN-2017 and 03-JUN-2017. The vaccine was exposed to a temperature of 47 Fahrenheit degrees for 16 hours on 09-JUN-2017, 13-JUN-2017, 22-JUN-2017, 23-JUN-2017, 28-JUN-2017 and 29-JUN-2017 and for 70 hours on 30-MAY-2017. The vaccine was exposed to a temperature of 35 Fahrenheit degrees for 16 hours on 27-JUN-2017, 20-JUL-2017 and 28-JUL-2017 and for 46 hours on 17-JUL-2017 and 26-JUN-2017. The vaccine was exposed to a temperature of 34 Fahrenheit degrees for 16 hours since 29-JUN-2017 until 01-JUL-2017, on 03-JUL-2017, 06-JUL-2017, 07-JUL-2017, 19-JUL-2017 and 26-JUL-2017, for 40 hours on 05-JUL-2017 and for 46 hours on 10-JUL-2017. The vaccine was exposed to a temperature of 33 Fahrenheit degrees for 16 hours on 08-JUL-2017 and since 11-JUL-2017 until 15-JUL-2017 and on 27-JUL-2017. The vaccine was also exposed to a temperature of 32 Fahrenheit degrees for 16 hours on 22-JUL-2017 and 01-AUG-2017. Additionally, it was reported that digital data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-1709USA012770: US-009507513-1709USA007325: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA012764: US-009507513-1709USA012766: US-009507513-1709USA012767: US-009507513-1711USA003164: US-009507513-1711USA003162: US-009507513-1711USA003161: US-009507513-1711USA003160: US-009507513-1711USA003159: US-009507513-1711USA003157: US-009507513-1711USA003165: US-009507513-1711USA003158:
This is a spontaneous report from a doctor of pharmacy referring to a 64 year old male pt who on 1/10/99, received the 2nd dose of Lymerix. Within 24 hours, post vax, he experienced bilateral shoulder stiffness and could not raise his arms. The most recent information, received on 7/5/99, reports the condition of the pt as ongoing.
Day 1 and 2: nausea, lack of appetite, headache, overall body aches, extreme fatigue, neck pain, temporal arteries pulsating, unable to sleep, dizziness, alternating chills, and feeling overheated.  Days 3 and 4: fatigue, slight appetite returning, alternating chills, and overheated diminishing but still continuing, a headache that won't go away, and dizziness.  Day 5: all symptoms subsided
bunch of pain in the kidney area - both sides; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PAIN (Body aches) and RENAL PAIN (bunch of pain in the kidney area - both sides) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced HEADACHE (Headache) and PAIN (Body aches). On 29-Mar-2021, the patient experienced RENAL PAIN (bunch of pain in the kidney area - both sides). At the time of the report, HEADACHE (Headache), PAIN (Body aches) and RENAL PAIN (bunch of pain in the kidney area - both sides) outcome was unknown. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications:Tylenol No concomitant medication information was provided by the reporter. No lab data has been provided by the reporter.
Nearly 24 hours after the vaccine -- a quick onset of fatigue, followed by chills and fever, body aches, erratic sleep, and very bad headache, lasting for more than than 24 hours later. I was unable to do anything other than stay in bed. watching TV wasn't an option with the long headache.  (and swollen arm, not so bad) It was 56 hours after the injection time that I was 'back to normal'.
Patient came in for FLUZONE HIGH DOSE on Saturday. Upon injection, I noticed there was a lot of resistance and it felt like nothing was going in, so I removed the syringe. While examining the syringe, I push down on the plunger harder and a lot of the medication came out. I did not readminister using the same syringe because the patient would not have gotten the proper dose. I prepared another one and injected him. This time it went smoothly. Spoke with patient on Sunday and he said he was fine and had no reaction.
was administered a dose of SHINGRIX VAC / that had been stored in a freezer  /had no symptoms; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received Herpes zoster (Shingrix) (batch number NE49X, expiry date 23rd August 2022) for prophylaxis.   On 29th April 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional case details were reported as follows: The health care professional (Medical Assistant) reported On 29th April 2021 the patient was administered a dose of Shingrix vaccine 1D 50MCG/O.5ML that had been stored in a freezer which led to incorrect storage of drug. The reporter contacted the patient and the patient had no symptoms, Product Storage Error was resolved. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. The Medical Assistant that administered the vaccine to the patient. This adverse event has been previously reported to the Vaccine Adverse Event Reporting System (VAERS) database by the medical clinic.
itching to left arm not relieved by Benadryl. No rash or redness
Client did not have an adverse reaction but report is being filled out d/t administering expired vaccine.
Child woke up at 6:30 am 03/13/2018 with fever of 102 and complaining of pain in his right arm. Mother states that his arm was red and swollen. Child ran fever off and on most of the day with highest temp at 102 degrees. MOTRIN did reduce fever. Child is present in clinic on 03/14/2018 with right deltoid that is red and swollen. Area is hot to touch. Child has no fever at present time. Child does complain of pain in area. Child states that it hurts his arm to move it.
Moderna Covid-19 vaccine drawn up into individual syringes at about 745pm - 8pm on 3/24/2021, vaccine was administered to patient at 12:15 pm  3/25/21, outside the recommended 6 hours after vial puncture. Vaccine remained in the refrigerator from the time drawn up to administration. Vaccine was inspected there was no particulate matter or discoloration prior to administration.
This spontaneous report was received from a nurse, concerning a 19 year old male patient. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On 28-MAY-2018, the patient was vaccinated with a pediatric dose of VAQTA for prophylaxis, lot #N023953 and expiration date 05-NOV-2018 (strength, dose, frequency and route of administration were not reported). No adverse effects were reported.
The evening after receiving the vaccine (received vaccine at approximately 2:45PM) the patient experienced itching all over. She called a 24 hour store and they told her to take 2 BENADRYL and if that didn't help to go to an Urgent Care or ER. The patient took a dose that evening and the next morning and was still itching a little but did not feel she needed to go to a doctor.
Patient received two Pfizer COVID vaccines in January 2021. She uses home oxygen, normally on 3L nasal cannula for COPD. She was tested COVID positive eight days prior to her admission to the hospital. She came to hospital ED due to increasing weakness on 12/19/21 and was subsequently admitted on 12/20/21. Hospital Day 2, she is afebrile. On 2-3 L Oxygen. She has received Remdesivir, Ceftriaxone, and Dexamethasone.
Per telephone call with PCP, pt had redness and warmth surrounding area vaccination was received. Pt complained of soreness to area.
pain in the back/sore back/lower back pain; pain in the lower back, kidneys and lungs; hotness; dizziness; could not stand; Covid-19-like symptoms; drunk-likeness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in the back/sore back/lower back pain), PAIN (pain in the lower back, kidneys and lungs), FEELING HOT (hotness), DIZZINESS (dizziness) and DYSSTASIA (could not stand) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, the patient experienced BACK PAIN (pain in the back/sore back/lower back pain), PAIN (pain in the lower back, kidneys and lungs), FEELING HOT (hotness), DIZZINESS (dizziness), DYSSTASIA (could not stand), SUSPECTED COVID-19 (Covid-19-like symptoms), FEELING DRUNK (drunk-likeness) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 29-May-2021, FEELING HOT (hotness), DIZZINESS (dizziness), DYSSTASIA (could not stand), FEELING DRUNK (drunk-likeness) and NAUSEA (nausea) had resolved. On 08-Jun-2021, BACK PAIN (pain in the back/sore back/lower back pain), PAIN (pain in the lower back, kidneys and lungs) and SUSPECTED COVID-19 (Covid-19-like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported by the reporter